-
Drug development for pediatric cancers: the importance of patient' s genomic data re-use
Blog
drug-development-for-pediatric-cancers
-
Highlights from 2025: Our top 10 requested studies
Blog
top-10-studies-2025
-
Deregulation of FOXF1/FENDRR from t(14;16)(q32;q24) defines a subtype of high risk lineage ambiguous leukemia
Study
EGAS50000001255
-
Mutant KIT as imatinib-sensitive target in metastatic sinonasal carcinoma (H021)
Study
EGAS00001001845
-
Robust detection of translocations in lymphoma FFPE samples using Targeted Locus Capture-based sequencing
Study
EGAS00001004760
-
Molecular evolution of metastatic clear cell renal cell carcinoma progressing under tyrosine kinase inhibitor therapy (HIPO-045)
Study
EGAS00001001861
-
EATL-II STUDY
Study
EGAS00001001879
-
Influence of age on molecular changes and treatment stratification in multimodal glioblastoma therapy
Study
EGAS00001008246
-
Inactivation of TGFβ receptors in stem cells drives cutaneous squamous cell carcinoma - 30 whole exomes
Study
EGAS00001001892
-
Comparison of EGF and PDGF driven glioblastomas.
Study
EGAS00001001900